H

Herantis Pharma Oyj
OMXH:HRTIS

Watchlist Manager
Herantis Pharma Oyj
OMXH:HRTIS
Watchlist
Price: 2.44 EUR -2.4% Market Closed
Market Cap: 58.8m EUR

Intrinsic Value

The intrinsic value of one HRTIS stock under the Base Case scenario is hidden EUR. Compared to the current market price of 2.44 EUR, Herantis Pharma Oyj is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

HRTIS Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Herantis Pharma Oyj

Intrinsic Value History
Dive into the past to invest in the future

HRTIS looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether HRTIS usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about HRTIS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is HRTIS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Herantis Pharma Oyj.

Explain Valuation
Compare HRTIS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HRTIS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Herantis Pharma Oyj

Current Assets 5.1m
Cash & Short-Term Investments 4.6m
Receivables 153k
Other Current Assets 400k
Current Liabilities 631k
Accounts Payable 282k
Accrued Liabilities 296k
Other Current Liabilities 53k
Non-Current Liabilities 2.7m
Long-Term Debt 2.7m
Efficiency

Free Cash Flow Analysis
Herantis Pharma Oyj

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Herantis Pharma Oyj

Revenue
0 EUR
Operating Expenses
-5.2m EUR
Operating Income
-5.2m EUR
Other Expenses
-227.8k EUR
Net Income
-5.5m EUR
Fundamental Scores

HRTIS Profitability Score
Profitability Due Diligence

Herantis Pharma Oyj's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
hidden
Profitability
Score

Herantis Pharma Oyj's profitability score is hidden . The higher the profitability score, the more profitable the company is.

HRTIS Solvency Score
Solvency Due Diligence

Herantis Pharma Oyj's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average Altman Z-Score
hidden
Solvency
Score

Herantis Pharma Oyj's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HRTIS Price Targets Summary
Herantis Pharma Oyj

Wall Street analysts forecast HRTIS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HRTIS is 1.63 EUR with a low forecast of 0.71 EUR and a high forecast of 2.63 EUR.

Lowest
Price Target
0.71 EUR
71% Downside
Average
Price Target
1.63 EUR
33% Downside
Highest
Price Target
2.63 EUR
8% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Herantis Pharma Oyj
does not pay dividends
Shareholder Yield

Current shareholder yield for HRTIS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one HRTIS stock?

The intrinsic value of one HRTIS stock under the Base Case scenario is hidden EUR.

Is HRTIS stock undervalued or overvalued?

Compared to the current market price of 2.44 EUR, Herantis Pharma Oyj is hidden .

Back to Top